Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(137 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(16 Videos)
Other
(12 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(18 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Region of the Body

See all (5)

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 16 results matching your search query: "Zoledronate"

Showing 1 - 16 of 16
Read Ace Report

Antiresorptive effects of single zoledronate dose are sustained for 3 years

J Bone Miner Res. 2010 Oct;25(10):2251-5

RCT Metabolic Disorders Osteopenia Postmenopausal Women Zoledronate Placebo - Hide
Read Ace Report

Substantial anti-resorptive effects achieved with 1mg and 2.5mg doses of zoledronate

J Clin Endocrinol Metab. 2012 Jan;97(1):286-92. doi: 10.1210/jc.2011-2081. Epub 2011 Nov 9

RCT General Orthopaedics Osteopenia Postmenopausal Women Zoledronate IV Infusion Placebo - Hide
Read Ace Report

Effects of 2.5mg zoledronate are long-lasting and similar to 5mg dose in osteopenic women

J Bone Miner Res. 2014 Jan;29(1):166-72. doi: 10.1002/jbmr.2009.

RCT General Orthopaedics Osteopenia Postmenopausal Women Axial Skeleton Spine Spine Lumbar Lower Extremity Hip Novartis Roche Zoledronate Infusion Placebo - Hide
Read Ace Report

Significant reduction in 6-year fragility fracture risk with zoledronate vs placebo for osteopenia

N Engl J Med. 2018 Dec 20;379(25):2407-2416. doi: 10.1056/NEJMoa1808082

RCT Metabolic Disorders Elderly Osteopenia Postmenopausal Women Lower Extremity Hip Bone Femur Neck Fracture Novartis Zoledronate Intravenous Infusion Placebo - Hide
Read Ace Report

Zoledronate reduces radiation-induced bone collagen degradation in radiation therapy

Clin Transl Oncol. 2015 Jun;17(6):454-61.

RCT Tumour Metastasis Novartis Zoledronate Collagen Radiation Therapy Radiotherapy Zoledronic - Hide
Read Ace Report

Alendronate & zoledronate both reduce hip and vertebral fracture risk compared to placebo

Gynecol Endocrinol. 2013 Dec;29(12):1005-14. doi: 10.3109/09513590.2013.813468. Epub 2013 Sep 25

Meta-analysis Metabolic Disorders Osteopenia Osteoporosis Postmenopausal Women Lower Extremity Hip Joint Vertebral Fracture Alendronate Zoledronate Placebo Zoledronic Acid - Hide
Read Ace Report

Zoledronic acid increases BMD at tibial epiphysis, but not tibial diaphysis

Maturitas. 2014 Mar;77(3):287-93

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Bone Tibia Joint Vertebral Fracture Novartis Zoledronate Placebo ZOL Zoledronic Acid - Hide
Read Ace Report

Network meta-analysis of current drug options for the treatment of osteoporosis in men

PLoS One. 2015 May 26;10(5):e0128032

Meta-analysis Metabolic Disorders Osteoporosis Axial Skeleton Spine Spine Lumbar Fracture Alendronate Risedronate Teriparatide Zoledronate Strontium Ranelate Alfacalcidol Current Ibandronate Placebo Reduction - Hide
Read Ace Report

Bisphosphonates do not reduce joint failure or THA in femoral head osteonecrosis patients

Osteoporos Int. 2016 Jan;27(1):295-9

Meta-analysis Metabolic Disorders Bone Femur Head Alendronate Zoledronate Arthroplasty Bisphosphonate Control Placebo Preventing THA - Hide
Read Ace Report

Comparison of risedronate, alendronate, zoledronate, and ibandronate in those with low BMD

Bone. 2016 Aug;89:52-8

Meta-analysis Metabolic Disorders Fracture Alendronate Risedronate Zoledronate Control Ibandronate Placebo Prevention Zoledronic Acid - Hide
Read Ace Report

Bisphosphonates prevent periprosthetic bone loss following arthroplasty over the mid-term

Osteoporos Int. 2012 Jun;23(6):1823-34. doi: 10.1007/s00198-011-1797-5. Epub 2011 Sep 20

Meta-analysis Arthroplasty Alendronate Zoledronate Clodronate Dual-Energy Factors Intramuscular Oral Pamidronate Prevention Prosthesis Replacement - Hide
Read Ace Report

Bisphosphonates effective in osteoporotic males in terms of fracture, BMD, and biomarkers

Osteoporos Int. 2015 Sep;26(9):2355-63.

Meta-analysis Metabolic Disorders Osteoporosis Fracture Alendronate Risedronate Zoledronate Bisphosphonate Control Ibandronate Intravenously Oral Placebo Serum - Hide
Read Ace Report

Bone mineral density loss following total joint arthroplasty mitigated by bisphosphonate therapy

Osteoporos Int. 2018 Jul;29(7):1525-1537. doi: 10.1007/s00198-018-4488-7

Meta-analysis Arthroplasty Lower Extremity Hip Knee Alendronate Zoledronate Clodronate Bisphosphonate Control Pamidronate Preservation Prosthesis Replacement THA TKA - Hide
Read Ace Report

Bisphosphates to prevent femoral periprosthetic bone resorption after cementless THA

J Orthop Surg Res. 2015 May 13;10(1):65

Meta-analysis Arthroplasty Lower Extremity Hip Bone Femur Alendronate Risedronate Zoledronate Clodronate Tiludronate Bisphosphonate Cementless THA Pamidronate Preventing Replacement - Hide
Read Ace Report

Network meta-analysis of anti-osteoporosis therapies for oral glucocorticoid users

Osteoporos Int. 2016 Jun;27(6):1989-98

Meta-analysis Metabolic Disorders Osteoporosis Fracture Alendronate Risedronate Glucocorticoid Denosumab Teriparatide Zoledronate Raloxifene Calcitonin Calcium Oral Placebo Preventing Replacement Vitamin - Hide
Read Ace Report

Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates

J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70

RCT Metabolic Disorders Osteoporosis Postmenopausal Women Amgen Denosumab Intravenous Injection Oral Subcutaneous Injections ZOL Zoledronic Acid - Hide
Showing 1 - 16 of 16